{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:31:49Z","timestamp":1782901909937,"version":"3.54.5"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10787-025-01945-1","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T14:20:25Z","timestamp":1758723625000},"page":"5735-5743","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Aspirin\u2019s effect on macrophages beyond its chemopreventive role in inflammation and cancer"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4925-7179","authenticated-orcid":false,"given":"Nese","family":"Unver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"1945_CR1","doi-asserted-by":"crossref","DOI":"10.1186\/1477-9560-2-1","volume":"2","author":"R Altman","year":"2004","unstructured":"Altman R, Luciardi HL, Muntaner J, Herrera RN (2004) The antithrombotic profile of aspirin. Aspirin resistance, or simply failure? Thromb J 2:1","journal-title":"Thromb J"},{"key":"1945_CR2","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1038\/s41598-018-36052-5","volume":"9","author":"AV Bagaev","year":"2019","unstructured":"Bagaev AV, Garaeva AY, Lebedeva ES, Pichugin AV, Ataullakhanov RI, Ataullakhanov FI (2019) Elevated pre-activation basal level of nuclear NF-kappaB in native macrophages accelerates LPS-induced translocation of cytosolic NF-kappaB into the cell nucleus. Sci Rep 9:4563","journal-title":"Sci Rep"},{"key":"1945_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.737934","author":"J Beck-Joseph","year":"2021","unstructured":"Beck-Joseph J, Lehoux S (2021) Molecular interactions between vascular smooth muscle cells and macrophages in atherosclerosis. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/fcvm.2021.737934","journal-title":"Front Cardiovasc Med"},{"key":"1945_CR4","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMoa067208","volume":"356","author":"AT Chan","year":"2007","unstructured":"Chan AT, Ogino S, Fuchs CS (2007) Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 356:2131\u20132142","journal-title":"N Engl J Med"},{"key":"1945_CR5","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.abc0269","volume":"372","author":"QJ Cheng","year":"2021","unstructured":"Cheng QJ, Ohta S, Sheu KM, Spreafico R, Adelaja A, Taylor B, Hoffmann A (2021) NF-kappaB dynamics determine the stimulus specificity of epigenomic reprogramming in macrophages. Science 372:1349\u20131353","journal-title":"Science"},{"key":"1945_CR6","first-page":"470","volume":"4","author":"N Chiang","year":"2004","unstructured":"Chiang N, Serhan CN (2004) Aspirin triggers formation of anti-inflammatory mediators: New mechanism for an old drug. Discov Med 4:470\u2013475","journal-title":"Discov Med"},{"key":"1945_CR7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/EBC20200018","volume":"64","author":"N Chiang","year":"2020","unstructured":"Chiang N, Serhan CN (2020) Specialized pro-resolving mediator network: an update on production and actions. Essays Biochem 64:443\u2013462","journal-title":"Essays Biochem"},{"key":"1945_CR8","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.0405445101","volume":"101","author":"N Chiang","year":"2004","unstructured":"Chiang N, Bermudez EA, Ridker PM, Hurwitz S, Serhan CN (2004) Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial. Proc Natl Acad Sci U S A 101:15178\u201315183","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1945_CR9","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/01.CIR.0000027816.54430.96","volume":"106","author":"T Cyrus","year":"2002","unstructured":"Cyrus T, Sung S, Zhao L, Funk CD, Tang S, Pratic\u00f2 D (2002) Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation 106:1282\u20131287","journal-title":"Circulation"},{"key":"1945_CR10","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl5420","volume":"8","author":"R DE Matteis","year":"2022","unstructured":"DE Matteis R, Flak MB, Gonzalez-Nunez M, Austin-Williams S, Palmas F, Colas RA, Dalli J (2022) Aspirin activates resolution pathways to reprogram T cell and macrophage responses in colitis-associated colorectal cancer. Sci Adv 8:eabl5420","journal-title":"Sci Adv"},{"key":"1945_CR11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3389\/fimmu.2019.00705","volume":"10","author":"MG Dorrington","year":"2019","unstructured":"Dorrington MG, Fraser IDC (2019) NF-kappaB signaling in macrophages: dynamics, crosstalk, and signal integration. Front Immunol 10:705","journal-title":"Front Immunol"},{"key":"1945_CR12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-3-642-30331-9_3","volume":"191","author":"M Dovizio","year":"2013","unstructured":"Dovizio M, Bruno A, Tacconelli S, Patrignani P (2013) Mode of action of aspirin as a chemopreventive agent. Recent Results Cancer Res 191:39\u201365","journal-title":"Recent Results Cancer Res"},{"key":"1945_CR13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","volume":"324","author":"DS Echt","year":"1991","unstructured":"Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL et al (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 324:781\u2013788","journal-title":"N Engl J Med"},{"key":"1945_CR14","volume":"11","author":"PC Elwood","year":"2016","unstructured":"Elwood PC, Morgan G, Pickering JE, Galante J, Weightman AL, Morris D, Kelson M, Dolwani S (2016) Aspirin in the treatment of cancer: reductions in metastatic spread and in mortality: a systematic review and meta-analyses of published studies. PLoS ONE 11:e0152402","journal-title":"PLoS ONE"},{"key":"1945_CR15","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1158\/1078-0432.CCR-06-2073","volume":"13","author":"J Forssell","year":"2007","unstructured":"Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R (2007) High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 13:1472\u20131479","journal-title":"Clin Cancer Res"},{"key":"1945_CR16","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1073\/pnas.1804000116","volume":"116","author":"MM Gilligan","year":"2019","unstructured":"Gilligan MM, Gartung A, Sulciner ML, Norris PC, Sukhatme VP, Bielenberg DR, Huang S, Kieran MW, Serhan CN, Panigrahy D (2019) Aspirin-triggered proresolving mediators stimulate resolution in cancer. Proc Natl Acad Sci U S A 116:6292\u20136297","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1945_CR17","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/15384047.2022.2104561","volume":"23","author":"A Grancher","year":"2022","unstructured":"Grancher A, Michel P, DI Fiore F, Sefrioui D (2022) Colorectal cancer chemoprevention: is aspirin still in the game? Cancer Biol Ther 23:446\u2013461","journal-title":"Cancer Biol Ther"},{"key":"1945_CR18","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/carcin\/bgw042","volume":"37","author":"Y Guo","year":"2016","unstructured":"Guo Y, Liu Y, Zhang C, Su ZY, Li W, Huang MT, Kong AN (2016) The epigenetic effects of aspirin: the modification of histone H3 lysine 27 acetylation in the prevention of colon carcinogenesis in azoxymethane- and dextran sulfate sodium-treated CF-1 mice. Carcinogenesis 37:616\u2013624","journal-title":"Carcinogenesis"},{"key":"1945_CR19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, Zeng C, Zhou T, Zhang J (2024) NF-kappaB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther 9:53","journal-title":"Signal Transduct Target Ther"},{"key":"1945_CR20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00011-010-0283-4","volume":"60","author":"A Javeed","year":"2011","unstructured":"Javeed A, Hou Y, Duan K, Zhang B, Shen H, Cao Y, Zhao Y (2011) Aspirin significantly decreases the nonopsonic phagocytosis and immunogenicity of macrophages in mice. Inflamm Res 60:389\u2013398","journal-title":"Inflamm Res"},{"key":"1945_CR21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.18632\/aging.102644","volume":"12","author":"W Jiang","year":"2020","unstructured":"Jiang W, Yan Y, Chen M, Luo G, Hao J, Pan J, Hu S, Guo P, Li W, Wang R, Zuo Y, Sun Y, Sui S, Yu W, Pan Z, Zou K, Zheng Z, Deng W, Wu X, Guo W (2020) Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-kappaB to the COX-2 promoter. Aging (Albany NY) 12:611\u2013627","journal-title":"Aging (Albany NY)"},{"key":"1945_CR22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainresbull.2017.05.009","volume":"132","author":"D Kata","year":"2017","unstructured":"Kata D, Foldesi I, Feher LZ, Hackler LJR, Puskas LG, Gulya K (2017) A novel pleiotropic effect of aspirin: beneficial regulation of pro- and anti-inflammatory mechanisms in microglial cells. Brain Res Bull 132:61\u201374","journal-title":"Brain Res Bull"},{"key":"1945_CR23","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s12903-023-03243-0","volume":"23","author":"E Khoshbin","year":"2023","unstructured":"Khoshbin E, Salehi R, Behroozi R, Sadr S, Zamani A, Farhadian M, Karkehabadi H (2023) The effect of low-dose aspirin on aspirin triggered lipoxin, interleukin 1 beta, and prostaglandin E2 levels in periapical fluid: a double-blind randomized clinical trial. BMC Oral Health 23:530","journal-title":"BMC Oral Health"},{"key":"1945_CR24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cyto.2003.11.007","volume":"25","author":"O Kutuk","year":"2004","unstructured":"Kutuk O, Basaga H (2004) Aspirin inhibits TNFalpha- and IL-1-induced NF-kappaB activation and sensitizes HeLa cells to apoptosis. Cytokine 25:229\u2013237","journal-title":"Cytokine"},{"key":"1945_CR25","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","volume":"20","author":"M Labelle","year":"2011","unstructured":"Labelle M, Begum S, Hynes RO (2011) Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 20:576\u2013590","journal-title":"Cancer Cell"},{"key":"1945_CR26","doi-asserted-by":"crossref","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T (2009) The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 1:a001651","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1945_CR27","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1056\/NEJMoa1207756","volume":"367","author":"X Liao","year":"2012","unstructured":"Liao X, Lochhead P, Nishihara R, Morikawa T, Kuchiba A, Yamauchi M, Imamura Y, Qian ZR, Baba Y, Shima K, Sun R, Nosho K, Meyerhardt JA, Giovannucci E, Fuchs CS, Chan AT, Ogino S (2012) Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med 367:1596\u20131606","journal-title":"N Engl J Med"},{"key":"1945_CR28","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1158\/0008-5472.CAN-19-0762","volume":"79","author":"LM Lichtenberger","year":"2019","unstructured":"Lichtenberger LM, Vijayan KV (2019) Are platelets the primary target of Aspirin\u2019s remarkable anticancer activity? Cancer Res 79:3820\u20133823","journal-title":"Cancer Res"},{"key":"1945_CR29","doi-asserted-by":"crossref","first-page":"11549","DOI":"10.1038\/s41598-017-10720-4","volume":"7","author":"Y Liu","year":"2017","unstructured":"Liu Y, Fang S, Li X, Feng J, Du J, Guo L, Su Y, Zhou J, Ding G, Bai Y, Wang S, Wang H, Liu Y (2017) Aspirin inhibits LPS-induced macrophage activation via the NF-kappaB pathway. Sci Rep 7:11549","journal-title":"Sci Rep"},{"key":"1945_CR30","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1158\/0008-5472.CAN-16-2501","volume":"77","author":"G Marelli","year":"2017","unstructured":"Marelli G, Erreni M, Anselmo A, Taverniti V, Guglielmetti S, Mantovani A, Allavena P (2017) Heme-oxygenase-1 production by intestinal CX3CR1(+) macrophages helps to resolve inflammation and prevents carcinogenesis. Cancer Res 77:4472\u20134485","journal-title":"Cancer Res"},{"key":"1945_CR31","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1073\/pnas.90.24.11693","volume":"90","author":"JA Mitchell","year":"1993","unstructured":"Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR (1993) Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A 90:11693\u201311697","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1945_CR32","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.4049\/jimmunol.0900477","volume":"183","author":"T Morris","year":"2009","unstructured":"Morris T, Stables M, Hobbs A, DE Souza P, Colville-Nash P, Warner T, Newson J, Bellingan G, Gilroy DW (2009) Effects of low-dose aspirin on acute inflammatory responses in humans. J Immunol 183:2089\u20132096","journal-title":"J Immunol"},{"key":"1945_CR33","doi-asserted-by":"crossref","first-page":"1134661","DOI":"10.3389\/fimmu.2023.1134661","volume":"14","author":"M Mussbacher","year":"2023","unstructured":"Mussbacher M, Derler M, Basilio J, Schmid JA (2023) NF-kappaB in monocytes and macrophages - an inflammatory master regulator in multitalented immune cells. Front Immunol 14:1134661","journal-title":"Front Immunol"},{"key":"1945_CR34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4251\/wjgo.v7.i10.221","volume":"7","author":"SE Norton","year":"2015","unstructured":"Norton SE, Ward-Hartstonge KA, Taylor ES, Kemp RA (2015) Immune cell interplay in colorectal cancer prognosis. World J Gastrointest Oncol 7:221\u2013232","journal-title":"World J Gastrointest Oncol"},{"key":"1945_CR35","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","volume":"353","author":"C Patrono","year":"2005","unstructured":"Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C (2005) Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 353:2373\u20132383","journal-title":"N Engl J Med"},{"key":"1945_CR36","doi-asserted-by":"crossref","first-page":"14978","DOI":"10.1073\/pnas.0809784106","volume":"106","author":"C Porta","year":"2009","unstructured":"Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, di Liberto D, Dieli F, Ghisletti S, Natoli G, de Baetselier P, Mantovani A, Sica A (2009) Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci U S A 106:14978\u201314983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1945_CR37","doi-asserted-by":"crossref","first-page":"G487","DOI":"10.1152\/ajpgi.00042.2011","volume":"301","author":"D Prescott","year":"2011","unstructured":"Prescott D, Mckay DM (2011) Aspirin-triggered lipoxin enhances macrophage phagocytosis of bacteria while inhibiting inflammatory cytokine production. Am J Physiol Gastrointest Liver Physiol 301:G487\u2013G497","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1945_CR38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1073\/pnas.0909765106","volume":"107","author":"G Rimon","year":"2010","unstructured":"Rimon G, Sidhu RS, Lauver DA, Lee JY, Sharma NP, Yuan C, Frieler RA, Trievel RC, Lucchesi BR, Smith WL (2010) Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1. Proc Natl Acad Sci U S A 107:28\u201333","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1945_CR39","volume":"18","author":"KM Rood","year":"2023","unstructured":"Rood KM, Patel N, Devengencie IM, Quinn JP, Gowdy KM, Costantine MM, Kniss DA (2023) Aspirin modulates production of pro-inflammatory and pro-resolving mediators in endothelial cells. PLoS ONE 18:e0283163","journal-title":"PLoS ONE"},{"key":"1945_CR40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2125.1986.tb05195.x","volume":"21","author":"B Rosenkranz","year":"1986","unstructured":"Rosenkranz B, Fischer C, Meese CO, Frolich JC (1986) Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man. Br J Clin Pharmacol 21:309\u2013317","journal-title":"Br J Clin Pharmacol"},{"key":"1945_CR41","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","volume":"376","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, Meade TW (2010) Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376:1741\u20131750","journal-title":"Lancet"},{"key":"1945_CR42","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","volume":"379","author":"PM Rothwell","year":"2012","unstructured":"Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z (2012) Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet 379:1591\u20131601","journal-title":"Lancet"},{"key":"1945_CR43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-2007-996108","volume":"23","author":"K Schror","year":"1997","unstructured":"Schror K (1997) Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Semin Thromb Hemost 23:349\u2013356","journal-title":"Semin Thromb Hemost"},{"key":"1945_CR44","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bpg.2011.10.016","volume":"25","author":"K Schror","year":"2011","unstructured":"Schror K (2011) Pharmacology and cellular\/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer. Best Pract Res Clin Gastroenterol 25:473\u2013484","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1945_CR45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.plefa.2005.05.002","volume":"73","author":"CN Serhan","year":"2005","unstructured":"Serhan CN (2005) Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids 73:141\u2013162","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"Suppl 1","key":"1945_CR46","first-page":"S200","volume":"153","author":"CN Serhan","year":"2008","unstructured":"Serhan CN, Chiang N (2008) Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol 153(Suppl 1):S200\u2013S215","journal-title":"Br J Pharmacol"},{"key":"1945_CR47","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.smim.2015.03.004","volume":"27","author":"CN Serhan","year":"2015","unstructured":"Serhan CN, Chiang N, Dalli J (2015) The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution. Semin Immunol 27:200\u2013215","journal-title":"Semin Immunol"},{"key":"1945_CR48","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1124\/mol.52.3.421","volume":"52","author":"RE Shackelford","year":"1997","unstructured":"Shackelford RE, Alford PB, Xue Y, Thai SF, Adams DO, Pizzo S (1997) Aspirin inhibits tumor necrosis factoralpha gene expression in murine tissue macrophages. Mol Pharmacol 52:421\u2013429","journal-title":"Mol Pharmacol"},{"key":"1945_CR49","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.actbio.2017.02.020","volume":"53","author":"MCP Sok","year":"2017","unstructured":"Sok MCP, Tria MC, Olingy CE, San Emeterio CL, Botchwey EA (2017) Aspirin-triggered resolvin D1-modified materials promote the accumulation of pro-regenerative immune cell subsets and enhance vascular remodeling. Acta Biomater 53:109\u2013122","journal-title":"Acta Biomater"},{"key":"1945_CR50","volume":"43","author":"M Sun","year":"2025","unstructured":"Sun M, Yu J, Wan J, Dou X, Chen X, Ye F (2025) Role of aspirin in cancer prevention. Cancer Treat Res Commun 43:100884","journal-title":"Cancer Treat Res Commun"},{"key":"1945_CR51","volume":"16","author":"W Sung","year":"2024","unstructured":"Sung W, Kim YS, Lee KY, Jung JA, Choi H, Lee YJ, Koh SH (2024) Aspirin modulates inflammatory biomarkers in patients with subcortical silent brain infarcts. Front Aging Neurosci 16:1507683","journal-title":"Front Aging Neurosci"},{"key":"1945_CR52","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1158\/1078-0432.CCR-14-2235","volume":"21","author":"AC Vidal","year":"2015","unstructured":"Vidal AC, Howard LE, Moreira DM, Castro-Santamaria R, Andriole GL, Freedland SJ (2015) Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study. Clin Cancer Res 21:756\u2013762","journal-title":"Clin Cancer Res"},{"key":"1945_CR53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cardiores.2004.12.024","volume":"66","author":"M Vinals","year":"2005","unstructured":"Vinals M, Bermudez I, Llaverias G, Alegret M, Sanchez RM, Vazquez-Carrera M, Laguna JC (2005) Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages. Cardiovasc Res 66:141\u2013149","journal-title":"Cardiovasc Res"},{"key":"1945_CR54","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.biopha.2009.04.033","volume":"64","author":"J Xue","year":"2010","unstructured":"Xue J, Hua YN, Xie ML, Gu ZL (2010) Aspirin inhibits MMP-9 mRNA expression and release via the PPARalpha\/gamma and COX-2\/mPGES-1-mediated pathways in macrophages derived from THP-1 cells. Biomed Pharmacother 64:118\u2013123","journal-title":"Biomed Pharmacother"},{"key":"1945_CR55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","volume":"396","author":"MJ Yin","year":"1998","unstructured":"Yin MJ, Yamamoto Y, Gaynor RB (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396:77\u201380","journal-title":"Nature"},{"key":"1945_CR56","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu H, Lin L, Zhang Z, Zhang H, Hu H (2020) Targeting NF-kappaB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther 5:209","journal-title":"Signal Transduct Target Ther"},{"key":"1945_CR57","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","volume":"162","author":"S Zelenay","year":"2015","unstructured":"Zelenay S, Van Der Veen AG, Bottcher JP, Snelgrove KJ, Rogers N, Acton SE, Chakravarty P, Girotti MR, Marais R, Quezada SA, Sahai E, Reis e Sousa C (2015) Cyclooxygenase-dependent tumor growth through evasion of immunity. Cell 162:1257\u20131270","journal-title":"Cell"},{"key":"1945_CR58","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3892\/mmr.2016.5456","volume":"14","author":"YP Zeng","year":"2016","unstructured":"Zeng YP, Yang C, Li Y, Fan Y, Yang HJ, Liu B, Sang HX (2016) Aspirin inhibits osteoclastogenesis by suppressing the activation of NF-kappaB and MAPKs in RANKL-induced RAW264.7 cells. Mol Med Rep 14:1957\u20131962","journal-title":"Mol Med Rep"},{"key":"1945_CR59","first-page":"5597","volume":"14","author":"P Zhang","year":"2017","unstructured":"Zhang P, Wu C, Huang XH, Shen CL, Li L, Zhang W, Yao CZ (2017) Aspirin suppresses TNF-alpha-induced MMP-9 expression via NF-kappaB and MAPK signaling pathways in RAW264.7 cells. Exp Ther Med 14:5597\u20135604","journal-title":"Exp Ther Med"},{"key":"1945_CR60","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/s40001-023-01342-w","volume":"28","author":"L Zhou","year":"2023","unstructured":"Zhou L, Zhang Z, Tian Y, Li Z, Liu Z, Zhu S (2023) The critical role of platelet in cancer progression and metastasis. Eur J Med Res 28:385","journal-title":"Eur J Med Res"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01945-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01945-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01945-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T19:05:34Z","timestamp":1761332734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01945-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1945"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01945-1","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}